INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. & Encourages Inves...
September 29 2016 - 3:49PM
Business Wire
Goldberg Law PC (the “Firm”) announces a class action lawsuit
has been filed against Seres Therapeutics, Inc. (“Seres” or the
“Company”) (Nasdaq: MCRB). Investors who purchased or otherwise
acquired shares between June 25, 2015 and July 29, 2016 (the “Class
Period”) are encouraged to contact the Firm in advance of the
November 28, 2016 lead plaintiff motion
deadline.
If you are a shareholder who suffered a loss during the Class
Period, click here to participate. In addition, we advise
you to contact Michael Goldberg or Brian Schall, of Goldberg Law
PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
According to the complaint, Seres made materially false and
misleading statements and/or failed to disclose material facts
about its lead drug product candidate SER-109, touting its
potential and efficacy. On July 29, 2016, the Company announced
that the Phase 2 clinical trial of SER-109 did not meet its primary
endpoint. When this news was released, shares of Seres fell in
value, causing investors harm.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160929006326/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comwww.Goldberglawpc.com
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Apr 2023 to Apr 2024